Yaacov, A.; Gillis, R.; Salim, J.; Katz, D.; Asna, N.; Paldor, I.; Grinshpun, A.
The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management. Cells 2026, 15, 57.
https://doi.org/10.3390/cells15010057
AMA Style
Yaacov A, Gillis R, Salim J, Katz D, Asna N, Paldor I, Grinshpun A.
The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management. Cells. 2026; 15(1):57.
https://doi.org/10.3390/cells15010057
Chicago/Turabian Style
Yaacov, Adar, Roni Gillis, Jaber Salim, Daniela Katz, Noam Asna, Iddo Paldor, and Albert Grinshpun.
2026. "The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management" Cells 15, no. 1: 57.
https://doi.org/10.3390/cells15010057
APA Style
Yaacov, A., Gillis, R., Salim, J., Katz, D., Asna, N., Paldor, I., & Grinshpun, A.
(2026). The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management. Cells, 15(1), 57.
https://doi.org/10.3390/cells15010057
